GALWAY, Ireland, November 14, 2023 Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has enrolled the 100th patient in its PATCH Clinical Study, a multi-center, single-arm, pivotal study evaluating the safety and efficacy of the Vivasure PerQseal® Closure Device System. The U.S. Food and Drug Administration (FDA) granted investigational device exemption (IDE) approval earlier this year to advance the PATCH study forward
The global vascular closure device market is growing at a CAGR of 7.1% from 2022 to 2030.Pune, India, Nov. 08, 2023 (GLOBE NEWSWIRE) A vascular closure device is a piece of collagen (a fibrous protein found in skin, connective tissue, and bone), a metallic clip, or a suture designed to close the small puncture produced in an artery following an angiography. According to our new research study on “Vascular Closure Device Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend
Left atrial appendage closure, also called LAA closure or LAAC, is a minimally invasive medical procedure used to drastically reduce the risk of stroke in.